The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Plasma MiR-21: A Potential Diagnostic Marker of Colorectal Cancer
Abstract
OBJECTIVES: The main objective of this study was to investigate the potential use of circulating microRNAs (miRNAs) as biomarkers of sporadic colorectal cancer (CRC). BACKGROUND: CRC, a leading cause of death, is curable if detected early. There is an unmet need for an accurate, noninvasive biomarker of CRC. MiRNAs are non-protein-coding RNAs regulating gene expression that play a role in CRC development. METHODS: Levels of 380 miRNAs were determined using microfluidic array technology (Applied Biosystems) in a "training" set of 30 CRC patients from whom cancer and adjacent normal tissue were collected. The 4 most dysregulated miRNAs (P < 0.05, false discovery rate (FDR): 10%) were then validated in a second blinded "test" set of 16 CRC patients from whom cancer and normal adjacent tissue had been collected. Validated tissue miRNAs were then evaluated in a plasma "test" set consisting of 30 CRC patients and 30 individuals without CRC. The most dysregulated tissue miRNAs were then validated in an independent new plasma test set consisting of 20 CRC patients with 20 age-, -, and race-matched subjects without CRC. RESULTS: Nineteen of 380 miRNAs were dysregulated in CRC tissue in the tissue "training" set (P < 0.05, FDR: 10%). The 2 most upregulated (miR-31; miR-135b) and most downregulated (miR-1; miR-133a) miRNAs identified CRC in our "test" set with 100% sensitivity and 80% specificity. MiR-31 was more upregulated in stages III and IV compared with stages I and II (P < 0.05). In the "plasma" group, miR-21 differentiated CRC patients from controls with 90% specificity and sensitivity. CONCLUSIONS: Plasma miRNAs provide reliable and noninvasive markers for CRC. Plasma miR-21 warrants study in larger cohorts. It seems uniquely promising as a plasma biomarker for CRC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005) · Cell · doi:10.1016/j.cell.2004.12.035 · Cited by 11,855
Measuring the Accuracy of Diagnostic Systems
Swets, J. A. (1988) · Science · doi:10.1126/science.3287615 · Cited by 10,058
Edge, S. B., & Compton, C. C. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-0985-4 · Cited by 9,029
Circulating microRNAs as stable blood-based markers for cancer detection
Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., Peterson, A., Noteboom, J., O'Briant, K. C., Allen, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804549105 · Cited by 7,969
MicroRNA signatures in human cancers
Calin, G. A., & Croce, C. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1997 · Cited by 7,590
Oncomirs—MicroRNAs with a role in cancer
Esquela-Kerscher, A., & Slack, F. J. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1840 · Cited by 5,884
The Genomic Landscapes of Human Breast and Colorectal Cancers
Wood, L. D., Parsons, D. W., Jones, S., Lin, J., Sjöblom, T., Leary, R. J., Shen, D., Boca, S. M., Barber, T., Ptak, J., et al. (2007) · Science · doi:10.1126/science.1145720 · Cited by 2,833
microRNAs as oncogenes and tumor suppressors
Zhang, B., Pan, X., Cobb, G. P., & Anderson, T. A. (2007) · Developmental Biology · doi:10.1016/j.ydbio.2006.08.028 · Cited by 2,749
MicroRNA-21 Is an Antiapoptotic Factor in Human Glioblastoma Cells
Chan, J. A., Krichevsky, A. M., & Kosik, K. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0137 · Cited by 2,557
Characterization of extracellular circulating microRNA
Turchinovich, A., Weiz, L., Langheinz, A., & Burwinkel, B. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr254 · Cited by 1,941
Asangani, I. A., Rasheed, S. A. K., Nikolova, D. A., Leupold, J. H., Colburn, N. H., Post, S., & Allgayer, H. (2008) · Oncogene · doi:10.1038/sj.onc.1210856 · Cited by 1,882
Lawrie, C. H., Gal, S., Dunlop, H. M., Pushkaran, B., Liggins, A. P., Pulford, K., Banham, A. H., Pezzella, F., Boultwood, J., Wainscoat, J. S., et al. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07077.x · Cited by 1,735
Si, M.-L., Zhu, S., Wu, H., Lu, Z., Wu, F., & Mo, Y.-Y. (2007) · Oncogene · doi:10.1038/sj.onc.1210083 · Cited by 1,600
Colon Cancer Survival Rates With the New American Joint Committee on Cancer Sixth Edition Staging
O'Connell, J. B., Maggard, M. A., & Ko, C. Y. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh275 · Cited by 1,599
MicroRNAs in body fluids—the mix of hormones and biomarkers
Cortez, M. A., Bueso-Ramos, C., Ferdin, J., Lopez-Berestein, G., Sood, A. K., & Calin, G. A. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.76 · Cited by 1,465
Ng, E. K. O., Chong, W. W. S., Jin, H., Lam, E. K. Y., Shin, V. Y., Yu, J., Poon, T. C. W., Ng, S. S. M., & Sung, J. J. Y. (2009) · Gut · doi:10.1136/gut.2008.167817 · Cited by 1,151
Cancer survival in five continents: a worldwide population-based study (CONCORD)
Coleman, M. P., Quaresma, M., Berrino, F., Lutz, J.-M., De Angelis, R., Capocaccia, R., Baili, P., Rachet, B., Gatta, G., Hakulinen, T., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70179-7 · Cited by 1,002
Meng, F., Henson, R., Lang, M., Wehbe, H., Maheshwari, S., Mendell, J. T., Jiang, J., Schmittgen, T. D., & Patel, T. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.02.057 · Cited by 984
Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer
Huang, Z., Huang, D., Ni, S., Peng, Z., Sheng, W., & Du, X. (2010) · International Journal of Cancer · doi:10.1002/ijc.25007 · Cited by 964
Roldo, C., Missiaglia, E., Hagan, J. P., Falconi, M., Capelli, P., Bersani, S., Calin, G. A., Volinia, S., Liu, C.-G., Scarpa, A., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.5194 · Cited by 775
OncomiRs: the discovery and progress of microRNAs in cancers
Cho, W. C. (2007) · Molecular Cancer · doi:10.1186/1476-4598-6-60 · Cited by 719
Circulating microRNAs as Novel Minimally Invasive Biomarkers for Breast Cancer
Heneghan, H. M., Miller, N., Lowery, A. J., Sweeney, K. J., Newell, J., & Kerin, M. J. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e3181cc939f · Cited by 687
Toyota, M., Suzuki, H., Sasaki, Y., Maruyama, R., Imai, K., Shinomura, Y., & Tokino, T. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0325 · Cited by 600
Circulating MicroRNAs: a novel class of biomarkers to diagnose and monitor human cancers
Zen, K., & Zhang, C. (2012) · Medicinal Research Reviews · doi:10.1002/med.20215 · Cited by 502
Regulation of the Adenomatous Polyposis Coli Gene by the miR-135 Family in Colorectal Cancer
Nagel, R., le Sage, C., Diosdado, B., van der Waal, M., Oude Vrielink, J. A. F., Bolijn, A., Meijer, G. A., & Agami, R. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0951 · Cited by 474
Circulating microRNAs: Association with disease and potential use as biomarkers
Reid, G., Kirschner, M. B., & van Zandwijk, N. (2011) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2010.11.004 · Cited by 467
Direct Serum Assay for MicroRNA-21 Concentrations in Early and Advanced Breast Cancer
Asaga, S., Kuo, C., Nguyen, T., Terpenning, M., Giuliano, A. E., & Hoon, D. S. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.151845 · Cited by 451
Colorectal Cancer Screening: Scientific Review
Walsh, J. M. E., & Terdiman, J. P. (2003) · JAMA · doi:10.1001/jama.289.10.1288 · Cited by 419
Serum MicroRNA Expression Profile as a Biomarker in the Diagnosis and Prognosis of Pancreatic Cancer
Liu, R., Chen, X., Du, Y., Yao, W., Shen, L., Wang, C., Hu, Z., Zhuang, R., Ning, G., Zhang, C., et al. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2011.172767 · Cited by 390
The global burden of urinary bladder cancer
Parkin, D. M. (2008) · Scandinavian Journal of Urology and Nephrology · doi:10.1080/03008880802285032 · Cited by 357
Fecal MicroRNAs as Novel Biomarkers for Colon Cancer Screening
Link, A., Balaguer, F., Shen, Y., Nagasaka, T., Lozano, J. J., Boland, C. R., & Goel, A. (2010) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0027 · Cited by 354
Epigenetic Silencing of miR-137 Is an Early Event in Colorectal Carcinogenesis
Balaguer, F., Link, A., Lozano, J. J., Cuatrecasas, M., Nagasaka, T., Boland, C. R., & Goel, A. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0622 · Cited by 293
Pu, X., Huang, G., Guo, H., Guo, C., Li, H., Ye, S., Ling, S., Jiang, L., Tian, Y., & Lin, T. (2010) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06417.x · Cited by 289
Prognostic and predictive factors in colorectal cancer
Zlobec, I., & Lugli, A. (2008) · Postgraduate Medical Journal · doi:10.1136/jcp.2007.054858 · Cited by 280
miR-21 and miR-31 Converge on TIAM1 to Regulate Migration and Invasion of Colon Carcinoma Cells
Cottonham, C. L., Kaneko, S., & Xu, L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.160069 · Cited by 265
Koga, Y., Yasunaga, M., Takahashi, A., Kuroda, J., Moriya, Y., Akasu, T., Fujita, S., Yamamoto, S., Baba, H., & Matsumura, Y. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0036 · Cited by 216
Collins, J. F., Lieberman, D. A., Durbin, T. E., Weiss, D. G., & and the Veterans Affairs Cooperative Study #380 Group* (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-2-200501180-00006 · Cited by 209
MicroRNA and Colorectal Cancer
Yang, L. G., Belaguli, N. S., & Berger, D. H. (2009) · World Journal of Surgery · doi:10.1007/s00268-008-9865-5 · Cited by 139
Kanaan, Z. M., Rai, S. N., Eichenberger, M. R., Barnes, C. N., Dworkin, A. M., Weller, C., Cohen, E. B., Roberts, H., Keskey, B., Petras, R. E., et al. (2012) · Human Mutation · doi:10.1002/humu.22021 · Cited by 123
Self-citationSample size for FDR-control in microarray data analysis
Jung, S. (2005) · Computer applications in the biosciences · doi:10.1093/bioinformatics/bti456 · Cited by 122
Galiveti, C. R., Rozhdestvensky, T. S., Brosius, J., Lehrach, H., & Konthur, Z. (2009) · RNA · doi:10.1261/rna.1755810 · Cited by 120
Chang, K. H., Miller, N., Kheirelseid, E. A. H., Lemetre, C., Ball, G., Smith, M. J. F., Regan, M., McAnena, O. J., & Kerin, M. J. (2011) · International Journal of Colorectal Disease · doi:10.1007/s00384-011-1279-4 · Cited by 118
Molecular markers and targets for colorectal cancer prevention
Janakiram, N. B., & Rao, C. V. (2008) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2008.00742.x · Cited by 94
MicroRNA and colorectal cancer
Corté, H., Manceau, G., Blons, H., & Laurent‐Puig, P. (2011) · Digestive and Liver Disease · doi:10.1016/j.dld.2011.10.010 · Cited by 82
MicroRNA-21 and PDCD4 expression in colorectal cancer
Chang, K. H., Miller, N., Kheirelseid, E. A. H., Ingoldsby, H., Hennessy, E., Curran, C. E., Curran, S., Smith, M. J. F., Regan, M. J., McAnena, O. J., et al. (2011) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2011.04.001 · Cited by 76
Rai, S. N., Ray, Yuan, Pan, Hamid, & Prabhu, S. D. (2012) · Open Access Medical Statistics · doi:10.2147/oams.s27907 · Cited by 19
Self-citation
Research works printed but not linked: 1
- Xiao, 2011, Retraction: microRNA miR-133 represses HERG K channel expression contributing to QT prolongation in diabetic hearts., J Biol Chem, 286, 28656, 10.1074/jbc.A111.700015 · doi:10.1074/jbc.a111.700015
Cited by
Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers
Okugawa, Y., Grady, W. M., & Goel, A. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.07.011 · Cited by 782
Epigenetics of colorectal cancer: biomarker and therapeutic potential
Jung, G., Hernández-Illán, E., Moreira, L., Balaguer, F., & Goel, A. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0230-y · Cited by 813
MicroRNA-Based Diagnosis and Therapy
Ho, P. T. B., Clark, I. M., & Le, L. T. T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137167 · Cited by 630
Serum miR-21 as a Diagnostic and Prognostic Biomarker in Colorectal Cancer
Toiyama, Y., Takahashi, M., Hur, K., Nagasaka, T., Tanaka, K., Inoue, Y., Kusunoki, M., Boland, C. R., & Goel, A. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djt101 · Cited by 499
The Impact of Hemolysis on Cell-Free microRNA Biomarkers
Kirschner, M. B., Edelman, J. J. B., Kao, S. C.-H., Vallely, M. P., van Zandwijk, N., & Reid, G. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00094 · Cited by 352
Metadata
- Authors
- Kanaan, Z., Rai, S. N., Eichenberger, M. R., Roberts, H., Keskey, B., Pan, J., & Galandiuk, S.
- Venue
- Annals of Surgery
- Published
- 2012-09
- Volume
- 256
- Issue
- 3
- Pages
- 544-551
- ISSN
- 0003-4932 (ISSN-L)
- OpenAlex
- W1992497862
- Cited by
- 269
- References
- 47
- FWCI
- 9.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.